Beacon Financial Group’s Novartis NVS Stock Holding History

Beacon Financial Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.17M	Sell	20,231 -267	-1%	-$40K	0.29%	82
2026 Q1	$3.13M	Buy	20,498 +245	+1%	+$37.6K	0.31%	83
2025 Q4	$2.79M	Sell	20,253 -196	-1%	-$25.7K	0.28%	86
2025 Q3	$2.62M	Sell	20,449 -115	-0.6%	-$14K	0.26%	94
2025 Q2	$2.49M	Sell	20,564 -84	-0.4%	-$9.47K	0.26%	101
2025 Q1	$2.3M	Sell	20,648 -982	-5%	-$105K	0.25%	98
2024 Q4	$2.1M	Sell	21,630 -219	-1%	-$23.4K	0.23%	101
2024 Q3	$2.51M	Sell	21,849 -771	-3%	-$87.5K	0.27%	91
2024 Q2	$2.41M	Sell	22,620 -167	-0.7%	-$16.8K	0.27%	93
2024 Q1	$2.2M	Sell	22,787 -1,204	-5%	-$123K	0.25%	101
2023 Q4	$2.42M	Buy	23,991 +763	+3%	+$73.6K	0.3%	88
2023 Q3	$2.33M	Sell	23,228 -4,865	-17%	-$494K	0.33%	83
2023 Q2	$2.79M	Sell	28,093 -1,241	-4%	-$124K	0.38%	75
2023 Q1	$2.81M	Sell	29,334 -3,942	-12%	-$344K	0.39%	73
2022 Q4	$3.03M	Buy	33,276 +355	+1%	+$29.9K	0.41%	71
2022 Q3	$2.53M	Buy	32,921 +1,391	+4%	+$115K	0.39%	72
2022 Q2	$2.65M	Sell	31,530 -249	-0.8%	-$21.8K	0.39%	76
2022 Q1	$2.81M	Buy	31,779 +1,466	+5%	+$127K	0.37%	74
2021 Q4	$2.66M	Buy	30,313 +262	+0.9%	+$21.8K	0.35%	80
2021 Q3	$2.49M	Buy	30,051 +781	+3%	+$70.3K	0.33%	82
2021 Q2	$2.64M	Buy	29,270 +2,228	+8%	+$198K	0.37%	77
2021 Q1	$2.56M	Hold	27,042	–	–	0.4%	75
2020 Q4	$2.56M	Sell	27,042 -295	-1%	-$25.8K	0.4%	76
2020 Q3	$2.38M	Sell	27,337 -1,526	-5%	-$132K	0.43%	68
2020 Q2	$2.52M	Sell	28,863 -43	-0.1%	-$3.71K	0.49%	65
2020 Q1	$2.37M	Buy	28,906 +281	+1%	+$25.1K	0.52%	56
2019 Q4	$2.71M	Buy	28,625 +2,269	+9%	+$204K	0.34%	69
2019 Q3	$2.3M	Sell	26,356 -671	-2%	-$60.2K	0.39%	72
2019 Q2	$2.47M	Sell	27,027 -3,149	-10%	-$267K	0.42%	71
2019 Q1	$2.6K	Sell	30,176 -113	-0.4%	-$9.07K	0.43%	66
2018 Q4	$2.31M	Sell	30,289 -1,721	-5%	-$134K	0.43%	69
2018 Q3	$2.47M	Sell	32,010 -1,102	-3%	-$81.5K	0.42%	73
2018 Q2	$2.24M	Sell	33,112 -1,432	-4%	-$98.8K	0.38%	73
2018 Q1	$2.5M	Sell	34,544 -173	-0.5%	-$13.2K	0.43%	67
2017 Q4	$2.61M	Buy	34,717 +256	+0.7%	+$19.3K	0.45%	62
2017 Q3	$2.65M	Buy	34,461 +7,492	+28%	+$566K	0.48%	56
2017 Q2	$2.04M	Buy	26,969 +2,738	+11%	+$194K	0.39%	60
2017 Q1	$1.62M	Buy	24,231 +3,935	+19%	+$262K	0.31%	69
2016 Q4	$1.32M	Buy	20,296 +2,109	+12%	+$137K	0.27%	73
2016 Q3	$1.29M	Sell	18,187 -44	-0.2%	-$3.21K	0.27%	71
2016 Q2	$1.33M	Sell	18,231 -936	-5%	-$64.7K	0.29%	65
2016 Q1	$1.25M	Sell	19,167 -1,238	-6%	-$84.2K	0.27%	68
2015 Q4	$1.6M	Sell	20,405 -613	-3%	-$48.7K	0.37%	62
2015 Q3	$1.69M	Buy	21,018 +399	+2%	+$35.5K	0.41%	60
2015 Q2	$1.82M	Buy	20,619 +1,025	+5%	+$94K	0.39%	61
2015 Q1	$1.78M	Buy	19,594 +51	+0.3%	+$4.52K	0.39%	63
2014 Q4	$1.63M	Sell	19,543 -2,365	-11%	-$196K	0.34%	72
2014 Q3	$1.84M	Sell	21,908 -26,000	-54%	-$2.1M	0.4%	69
2014 Q2	$3.88M	Sell	47,908 -34,670	-42%	-$2.73M	0.86%	42
2014 Q1	$6.04M	Sell	82,578 -5,124	-6%	-$373K	1.24%	18
2013 Q4	$6.31M	Sell	87,702 -1,846	-2%	-$128K	1.21%	17
2013 Q3	$9.19M	Buy	+89,548	New	+$5.92M	1.98%	9

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Beacon Financial Group's NVS Position: Q2 2026 in Review

Beacon Financial Group reduced its Novartis (NVS) stake by 1.3% in Q2 2026, selling an estimated $40K and leaving 20,231 shares worth $3.17M. The position accounts for 0.29% of the portfolio, ranked #82.

Beacon Financial Group first reported a position in NVS in Q3 2013 and has held it in 52 quarters since. The position peaked at $9.19M in Q3 2013. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Beacon Financial Group held 20,231 shares of Novartis worth $3.17M as of Q2 2026.
Beacon Financial Group sold 267 Novartis shares in Q2 2026, an estimated $40K.
Novartis made up 0.29% of Beacon Financial Group's portfolio in Q2 2026, its #82 holding.
Beacon Financial Group first reported a position in Novartis in Q3 2013 and has held it in 52 quarters since.
Beacon Financial Group's Novartis position peaked at $9.19M in Q3 2013.
1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Beacon Financial Group's 13F filing for Q2 2026, filed 16 Jul 2026.